Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

MiPT: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
← Older editNewer edit →
>White
m Text replacement - "{| |- | 17px''Main articles: Research chemicals § Toxicity and harm potential'' ''&'' ''Responsible use § Hallucinogens'' |}" to "{{further|Research chemicals#Toxicity and harm potential|Responsible use #Hallucinogens}}"
>BronzeManul
m Corrected legal status in UK to being Class A in Misuse of Drugs Act 1971 and thus not covered by the Psychoactive Substances Act 2016. Correc
Line 91: Line 91:
Due to its relative obscurity, the possession and sale of MiPT is unscheduled in most countries.  
Due to its relative obscurity, the possession and sale of MiPT is unscheduled in most countries.  


*'''United Kingdom''' - It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.<ref>Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted</ref>
*'''United Kingdom''' - MiPT is a Class A drug in the United Kingdom as a result of the tryptamine catch-all clause.<ref>Misuse of Drugs Act 1971 (Legislation.gov.uk) |http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I#reference-M_F_c7632653-ddad-4420-f307-e3da1e36d30e</ref>
*'''USA''' - MiPT is unscheduled in the United States. It may be considered controlled as an analog of another stimulant, alpha-methyl-tryptamine, but this has not been tested in court.
*'''United States''' - MiPT is unscheduled in the United States. It may be considered an analogue of [[DMT]], which is a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption or the use for illicit non-medical or industrial intents and purposes could be prosecuted as crimes under the Federal Analogue Act.{{citation needed}}


==See also==
==See also==

Revision as of 22:22, 17 April 2017

Template:Proofread

MiPT
Chemical Nomenclature
Common names MiPT
Substitutive name N-Methyl-N-isopropyltryptamine
Systematic name N-[2-(1H-indol-3-yl)ethyl]-N-methylpropan-2-amine
Class Membership
Psychoactive class Psychedelic
Chemical class Tryptamine
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.



⇣ Oral
Dosage
Common 10 - 25 mg
Strong 25 - 75 mg
Heavy 75 - 200 mg
Duration
Total 3 - 8 hours









DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

Interactions
Summary sheet: MiPT

MiPT (also known as N-methyl-N-isopropyltryptamine) is a hallucinogenic psychedelic drug of the tryptamine class.

Alexander Shulgin first synthesized MiPT and documented it in his book TiHKAL (Tryptamines I Have Known and Loved). It is the methyl analog of DiPT.[1]

Today it is either used recreationally or as an entheogenic compound and is typically acquired through the use of online research chemical vendors. It remains relatively uncommon even for a substituted tryptamine and has very little history of human usage.

Chemistry

This chemistry section is incomplete.

You can help by adding to it.

Pharmacology

Further information: Serotonergic psychedelic

Like with most psychedelic tryptamines, MiPT is thought to act principally as a 5-HT2A partial agonist. The psychedelic effects are believed to come from MiPT's binding efficacy at the 5-HT2A receptors.

However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.

Subjective effects

 This subjective effects section is a stub.

As such, it is still in progress and may contain incomplete or wrong information.

You can help by expanding or correcting it.

Disclaimer: The effects listed below cite the Subjective Effect Index (SEI), an open research literature based on anecdotal user reports and the personal analyses of PsychonautWiki contributors. As a result, they should be viewed with a healthy degree of skepticism.

It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. Likewise, adverse effects become increasingly likely with higher doses and may include addiction, severe injury, or death ☠. The sensory effects of MiPT are said to be similar to those of DiPT but with less intensity at the same dose.

Physical effects

Cognitive effects

Visual effects

Enhancements

Distortions

Geometry

Hallucinatory states

Auditory effects

Experience reports

There are currently no anecdotal reports which describe the effects of this compound within our experience index. Additional experience reports can be found here:

Toxicity and harm potential

Further information: Research chemicals § Toxicity and harm potential, and Responsible use § Hallucinogens

The toxicity and long-term health effects of recreational MiPT use do not seem to have been studied in any scientific context and the exact toxic dose is unknown. This is because MiPT is a research chemical with very little history of human usage. Anecdotal evidence from people within the psychonaut community who have tried MiPT suggests that there are no negative health effects attributed to simply trying the drug by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). Independent research should always be done to ensure that a combination of two or more substances is safe before consumption.

It is strongly recommended that one use harm reduction practices when using this drug.

Tolerance and addiction potential

MiPT is not habit-forming and the desire to use it can actually decrease with regular consumption. Like with most psychedelics, it is most often thought to be self-regulating.

Tolerance to the effects of MiPT are built almost immediately after ingestion. After that, it takes about 3 days for the tolerance to be reduced to half and 7 days to be back at baseline (in the absence of further consumption). MiPT presents cross-tolerance with [[Cross-tolerance::all psychedelics]], meaning that after the consumption of MiPT all psychedelics will have a reduced effect.

Due to its relative obscurity, the possession and sale of MiPT is unscheduled in most countries.

  • United Kingdom - MiPT is a Class A drug in the United Kingdom as a result of the tryptamine catch-all clause.[2]
  • United States - MiPT is unscheduled in the United States. It may be considered an analogue of DMT, which is a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption or the use for illicit non-medical or industrial intents and purposes could be prosecuted as crimes under the Federal Analogue Act.[citation needed]

See also

References

  1. ↑ https://www.erowid.org/library/books_online/tihkal/tihkal47.shtml Entry in TIHKAL
  2. ↑ Misuse of Drugs Act 1971 (Legislation.gov.uk) |http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I#reference-M_F_c7632653-ddad-4420-f307-e3da1e36d30e
Retrieved from "http://psy.st/w/index.php?title=MiPT&oldid=85221"